Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalDrug Metabolism and Disposition
Volume39
Issue number5
Pages (from-to)904-911
ISSN0090-9556
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 317 Pharmacy
  • Clinical Pharmacology

Cite this

@article{291f1c4ba21542e699bc4330d2925b29,
title = "Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations",
keywords = "317 Pharmacy, Clinical Pharmacology",
author = "Filppula, {Anne M.} and Jouko Laitila and Neuvonen, {Pertti J.} and Backman, {Janne T.}",
year = "2011",
doi = "10.1124/dmd.110.037689",
language = "English",
volume = "39",
pages = "904--911",
journal = "Drug Metabolism and Disposition",
issn = "1521-009X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations. / Filppula, Anne M.; Laitila, Jouko; Neuvonen, Pertti J.; Backman, Janne T.

In: Drug Metabolism and Disposition, Vol. 39 , No. 5, 2011, p. 904-911.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations

AU - Filppula, Anne M.

AU - Laitila, Jouko

AU - Neuvonen, Pertti J.

AU - Backman, Janne T.

PY - 2011

Y1 - 2011

KW - 317 Pharmacy

KW - Clinical Pharmacology

U2 - 10.1124/dmd.110.037689

DO - 10.1124/dmd.110.037689

M3 - Article

VL - 39

SP - 904

EP - 911

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 1521-009X

IS - 5

ER -